Етрузил

Етрузил (Letrozole) is an oral prescription medication used primarily for hormone receptor-positive breast cancer in postmenopausal women. This nonsteroidal aromatase inhibitor helps reduce estrogen levels to slow cancer cell growth. Consult a healthcare provider for suitability and dosing.

Етрузил (Letrozole) is used to treat hormone receptor-positive breast cancer in postmenopausal women. It works by lowering estrogen levels in the body, which can help slow or stop the growth of certain cancer cells. This medication is often prescribed after surgery or other initial treatments to reduce the risk of cancer recurrence.

Common effects of Етрузил may include hot flashes, joint pain, and fatigue. Some users report mild nausea or dizziness, especially when starting treatment. These effects are typically temporary and vary by individual. Bone density may also be affected over time, so regular monitoring is advised.

Keep Етрузил in a cool, dry place away from direct sunlight. Store it securely, out of reach of children and pets. Do not use if the packaging is damaged or the medication appears altered. Inform your healthcare provider about all current medications and health conditions before starting treatment.

Етрузил may interact with other hormone therapies, tamoxifen, or estrogen-containing products. Caution is advised when combining with medications that affect liver enzymes, such as certain antidepressants or antifungals. Alcohol and grapefruit products may also influence its effects. Always disclose your full medication list to your doctor.